OPTIMAL ADMINISTRATION DURATION OF URACIL-TEGAFUR ON ADJUVANT CHEMOTHERAPY FOR COMPLETELY RESECTED STAGE I LUNG ADENOCARCINOMA: RETROSPECTIVE ANALYSIS FROM JLCRG PHASE III STUDY

被引：0
|
作者：
Tsuboi, M. [1 ]
Hamada, C. [2 ]
机构：
[1] Kanagawa Canc Ctr, Yokohama, Kanagawa 2410815, Japan
[2] Tokyo Univ Sci, Fac Engn, Tokyo 162, Japan
[3] Japan Lung Canc Res Grp, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：154 / 154
页数：1
相关论文
共 50 条
  • [41] Gefitinib in the adjuvant setting: safety results from a phase III study in patients with completely resected non-small cell lung cancer
    Tsuboi, M
    Kato, H
    Nagai, K
    Tsuchiya, R
    Wada, H
    Tada, H
    Ichinose, Y
    Fukuoka, M
    Jiang, HY
    ANTI-CANCER DRUGS, 2005, 16 (10) : 1123 - 1128
  • [42] Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
    Norihito Okumura
    Junichi Soh
    Hiroyuki Suzuki
    Masao Nakata
    Toshiya Fujiwara
    Hiroshige Nakamura
    Makoto Sonobe
    Takuji Fujinaga
    Kazuhiko Kataoka
    Kenichi Gemba
    Masafumi Kataoka
    Katsuyuki Hotta
    Hiroshige Yoshioka
    Keitaro Matsuo
    Junichi Sakamoto
    Hiroshi Date
    Shinichi Toyooka
    BMC Cancer, 21
  • [43] Randomized phase II study of daily and alternate-day administration of S-1 for adjuvant chemotherapy in completely-resected stage I non-small cell lung cancer: results of the Setouchi Lung Cancer Group Study 1301
    Okumura, Norihito
    Soh, Junichi
    Suzuki, Hiroyuki
    Nakata, Masao
    Fujiwara, Toshiya
    Nakamura, Hiroshige
    Sonobe, Makoto
    Fujinaga, Takuji
    Kataoka, Kazuhiko
    Gemba, Kenichi
    Kataoka, Masafumi
    Hotta, Katsuyuki
    Yoshioka, Hiroshige
    Matsuo, Keitaro
    Sakamoto, Junichi
    Date, Hiroshi
    Toyooka, Shinichi
    BMC CANCER, 2021, 21 (01)
  • [44] ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I-III) non small cell lung cancer (NSCLC) patients (pts)
    Rosell, R
    de Lena, M
    Carpagnano, F
    Ramlau, R
    Gonzalez-Larriba, J
    Grodzki, T
    Le Groumellec, A
    Aubert, D
    Gasmi, J
    Douillard, J
    LUNG CANCER, 2005, 49 : S3 - S4
  • [45] International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer
    Novello, S.
    Torri, V
    Grohe, C.
    Kurz, S.
    Serke, M.
    Wehler, T.
    Meyer, A.
    Ladage, D.
    Geissler, M.
    Colantonio, I
    Cauchi, C.
    Stoelben, E.
    Ceribelli, A.
    Kropf-Sanchen, C.
    Valmadre, G.
    Borra, G.
    Schena, M.
    Morabito, A.
    Santo, A.
    Gregorc, V
    Chiari, R.
    Reck, M.
    Schmid-Bindert, G.
    Folprecht, G.
    Griesinger, F.
    Follador, A.
    Pedrazzoli, P.
    Bearz, A.
    Caffo, O.
    Dickgreber, N. J.
    Irtelli, L.
    Wiest, G.
    Monica, V
    Porcu, L.
    Manegold, C.
    Scagliotti, G., V
    ANNALS OF ONCOLOGY, 2022, 33 (01) : 57 - 66
  • [46] The effect of epidermal growth factor receptor mutation on adjuvant chemotherapy with tegafur/uracil for patients with completely resected, non-lymph node metastatic non-small cell lung cancer (> 2 cm): a multicenter, retrospective, observational study as exploratory analysis of the CSPOR-LC03 study
    Miyoshi, Tomohiro
    Aokage, Keiju
    Watanabe, Shun-ichi
    Ito, Hiroyuki
    Sakakura, Noriaki
    Mun, Mingyon
    Yamashita, Motohiro
    Ohde, Yasuhisa
    Aoki, Tadashi
    Nishio, Wataru
    Taguri, Masataka
    Tsuboi, Masahiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (11) : 1185 - 1193
  • [47] Open-label, multi-center, phase II study of adjuvant pemetrexed plus cisplatin for completely resected stage IB to IIIA adenocarcinoma of the lung: APICAL trial
    Park, Cheol-Kyu
    Oh, Hyung-Joo
    Yoo, Seung Soo
    Lee, Shin Yup
    Lee, Sang Hoon
    Kim, Eun Young
    Lee, Sung Yong
    Choi, Juwhan
    Lee, Min Ki
    Kim, Mi-Hyun
    Jang, Tae Won
    Chung, Chaeuk
    Oh, In-Jae
    Kim, Young-Chul
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (08) : 1606 - 1618
  • [48] A phase III clinical trial of adjuvant chemotherapy versus chemoimmunotherapy for stage IB-IIIA completely resected non-small cell lung cancer (NSCLC) patients nadim-adjuvant: New adjuvant trial of chemotherapy versus chemoimmunotherapy.
    Calvo, Virginia
    Domine, Manuel
    Sullivan, Ivana
    Gonzalez-Larriba, Jose-Luis
    Ortega, Ana Laura
    Bernabe, Reyes
    Sala, Maria Angeles
    Campos, Begona
    De Castro, Javier
    Martin-Martorell, Paloma
    Bosch-Barrera, Joaquim
    Mielgo, Xabier
    Vila, Laia
    Casal, Joaquin
    Ros, Silver
    Aguillo, Maite Martinez
    Padilla, Airam
    Sandiego, Sergio
    Machado, Jonathan Aires
    Provencio-Pulla, Mariano
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [49] A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer
    Schmid-Bindert, Gerald
    Engel-Riedel, Walburga
    Reck, Martin
    Schuette, Wolfgang
    Stoehlmacher, Jan
    Fischer, Juergen R.
    Mazieres, Julien
    Chouaid, Christos
    Wolf, Martin
    Vinolas, Nuria
    Soldatenkova, Victoria
    Ripoche, Veronique
    Nguyen, Tuan
    Visseren-Grul, Carla
    LUNG CANCER, 2015, 90 (03) : 397 - 404
  • [50] Planned Safety Analysis of the ACTS-CC 02 Trial: A Randomized Phase III Trial of S-1 With Oxaliplatin Versus Tegafur and Uracil With Leucovorin as Adjuvant Chemotherapy for High-Risk Stage III Colon Cancer
    Kusumoto, Tetsuya
    Sunami, Eiji
    Ota, Mitsuyoshi
    Yoshida, Kazuhiro
    Sakamoto, Yoshiyuki
    Tomita, Naohiro
    Maeda, Atsuyuki
    Mochizuki, Izumi
    Okabe, Michio
    Kunieda, Katsuyuki
    Yamauchi, Junichiro
    Itabashi, Michio
    Kotake, Kenjiro
    Takahashi, Keiichi
    Baba, Hideo
    Boku, Narikazu
    Aiba, Keisuke
    Ishiguro, Megumi
    Morita, Satoshi
    Sugihara, Kenichi
    CLINICAL COLORECTAL CANCER, 2018, 17 (02) : E153 - E161
12345